Showing results (421-430 of 675) with videos related to
Sort By:
Pageof 68
Nature Genetics|November 20, 2024
Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterationsMarc J Williams, Michael U J Oliphant, Vinci Au, et al.JCO Precision Oncology|May 22, 2026
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient PopulationMatilde Borio, Margaret Sheehan, Nora Katabi, et al.JCO Precision Oncology|August 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid TumorsSebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, et al.Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.Nature Genetics|August 30, 2011
Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner, Anna C Obenauf, Rajmohan Murali, et al.Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.American Journal of Human Genetics|August 7, 2012
Rare de novo germline copy-number variation in testicular cancerZsofia K Stadler, Diane Esposito, Sohela Shah, et al.Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.Pageof 68